RS
Elite in Metastatic Brain Tumor
Check Dr. Roger Stupp's experience treating your condition:
About Dr. Roger Stupp

Roger Stupp is a Hematologist Oncology specialist and a Neurologist in Chicago, Illinois. Stupp has been practicing medicine for over 36 years and is rated as an Elite expert by MediFind in the treatment of Metastatic Brain Tumor. He is also highly rated in 15 other conditions, according to our data. His top areas of expertise are Astrocytoma, Glioblastoma, Glioma, and Gliomatosis Cerebri. He is licensed to treat patients in Illinois. Stupp is currently accepting new patients.

His clinical research consists of co-authoring 240 peer reviewed articles and participating in 7 clinical trials in the past 15 years. In particular, he has co-authored 17 articles and participated in 1 clinical trial in the study of Metastatic Brain Tumor.

Insurance

MediFind strives to display the most accurate insurance information for every doctor. If you do not see your insurance listed for Dr. Roger Stupp it is best to call his office and ask if your insurance is accepted.

Accepts Medicare

Call to see if your plan is accepted.
Locations
675 N Saint Clair St, Chicago, IL 60611
Background & Education
Graduate Institution
Other, 1987
Specialties
Hematology Oncology
Neurology
Licenses
Psychiatry & Neurology in IL
Hospital Affiliations
Northwestern Medicine Lake Forest Hospital
Northwestern Medicine Central DuPage Hospital
Northwestern Memorial Hospital
Languages Spoken
English
Dutch
French
Korean
Spanish
Gender
Male
Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Doctors who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.


7 Clinical Trials

Phase 1 / 2 Trial of Blood-brain Barrier Opening With an Implantable Ultrasound Device SonoCloud-9 and Treatment With Albumin-bound Paclitaxel and Carboplatin in Patients With Recurrent Glioblastoma
A Phase II Randomized Trial of Proton Vs. Photon Therapy (IMRT) for Cognitive Preservation in Patients With IDH Mutant, Low to Intermediate Grade Gliomas
Preoperative Chemoradiotherapy vs. Chemotherapy Alone in Non-small Cell Lung Cancer (NSCLC) Patients With Mediastinal Lymph Node Metastases (Stage IIIA, N2): A Randomized Prospective Phase III Trial
A Phase IB/IIA, Single-centered Study of the Effects of OXY111A in Primary and Secondary Hepato-Pancreato-Biliary Neoplasia
A Prospective, Multi-center Trial of NovoTTF-100A Compared to Best Standard of Care in Patients With Progressive or Recurrent GBM
View 5 Less Clinical Trials -

Save this doctor for later
Sign Up
Looking for the best doctor for you?
Start Here
Is this your doctor?
Find a second opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn more
Similar Doctors
Elite
Distinguished
Distinguished